The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension

The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension

Objective. The VICTORY study aimed to evaluate effectiveness and safety of monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in clinical practice in patients with stage 1 and stage 2 hypertension. Materials and methods. In the prospective, random...

Full description

Bibliographic Details
Main Authors: I E Chazova, T V Martynyuk, R Accetto, Yu Sirenko, J Vincelj, Jr JWidimsky, B Barbič-Žagar, M V Arhipov, Yu I Grinshtein, O D Ostroumova, A S Galjavich, O P Rotar', L A Haisheva, S V Nedogoda
Format: Article
Language:Russian
Published: IP Morozov P.V. 2017-06-01
Series:Системные гипертензии
Subjects:
hypertension
combined antihypertensive therapy
valsartan
hydrochlorothiazide
Online Access:https://syst-hypertension.ru/2075-082X/article/viewFile/29204/pdf

Internet

https://syst-hypertension.ru/2075-082X/article/viewFile/29204/pdf

Similar Items